Total medical devices industry cross border M&A deals worth $1.1bn were announced in Europe in Q3 2022, led by Azenta’s $468.22m acquisition of B Medical Systems, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 51.6% over the previous quarter and a drop of 52.5% when compared with the last four-quarter average of $2.21bn.
Europe held a 70.47% share of the global medical devices industry cross border M&A deal value that totalled $1.49bn in Q3 2022. With a 31.42% share and deals worth $468.22m, Luxembourg was the top country in Europe’s cross border M&A deal value across medical devices industry.
In terms of deal activity, Europe recorded 28 cross border deals during Q3 2022, marking a decrease of 36.36% over the previous quarter and a drop of 26.80% over the last four-quarter average. Germany recorded five deals during the quarter.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataEurope medical devices industry cross border M&A deals in Q3 2022: Top deals
The top five medical devices industry cross border M&A deals accounted for 98.5% of the overall value during Q3 2022.
The combined value of the top five cross border M&A deals stood at $1.04bn, against the overall value of $1.1bn recorded for the quarter.
The top five medical devices industry cross border deals of Q3 2022 tracked by GlobalData were:
1) Azenta’s $468.22m acquisition deal with B Medical Systems
2) The $243.32m acquisition of Medi-Globe by DCC Healthcare
3) Bio-Rad Laboratories’s $170m acquisition deal with Curiosity Diagnostics
4) The $137.14m acquisition of Genome Diagnostics by Eurobio Scientific
5) 908 Devices’s $17.3m acquisition deal with TRACE Analytics